We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
3576
Cytokinetics
CYTK
$10.6B
$210K ﹤0.01%
3,873
-4,031
-51% -$243K
IYLD icon
3577
iShares Morningstar Multi-Asset Income ETF
IYLD
$125M
$210K ﹤0.01%
10,571
-200
-2% -$3.97K
ARIS
3578
Aris Mining
ARIS
$3.58B
$209K ﹤0.01%
55,533
-26,442
-32% -$106K
TPG icon
3579
TPG
TPG
$8.12B
$207K ﹤0.01%
5,000
PCM
3580
PCM Fund
PCM
$70.3M
$207K ﹤0.01%
27,901
+686
+3% +$5.75K
PVAL icon
3581
Putnam Focused Large Cap Value ETF
PVAL
$13.8B
$207K ﹤0.01%
+5,692
New +$203K
TLTW icon
3582
iShares 20+ Year Treasury Bond BuyWrite Strategy ETF
TLTW
$1.83B
$207K ﹤0.01%
8,045
-193
-2% -$4.93K
ESTA icon
3583
Establishment Labs
ESTA
$2.21B
$207K ﹤0.01%
+4,546
New +$231K
RSPU icon
3584
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$531M
$206K ﹤0.01%
3,556
-5
-0.1% -$292
KRMD icon
3585
KORU Medical Systems
KRMD
$159M
$206K ﹤0.01%
77,800
+52,200
+204% +$119K
GNL icon
3586
Global Net Lease
GNL
$1.91B
$205K ﹤0.01%
27,959
-7,500
-21% -$54.4K
MJ icon
3587
Amplify Alternative Harvest ETF
MJ
$109M
$205K ﹤0.01%
5,158
-109
-2% -$5.09K
WOOD icon
3588
iShares Global Timber & Forestry ETF
WOOD
$270M
$205K ﹤0.01%
2,622
+34
+1% +$2.77K
ROIC
3589
DELISTED
Retail Opportunity Investments Corp.
ROIC
$205K ﹤0.01%
16,523
-4,910
-23% -$60.8K
KIO
3590
KKR Income Opportunities Fund
KIO
$459M
$204K ﹤0.01%
14,901
+1,516
+11% +$20.3K
ACRE
3591
Ares Commercial Real Estate
ACRE
$262M
$204K ﹤0.01%
30,654
-2,051
-6% -$14.2K
TR icon
3592
Tootsie Roll Industries
TR
$2.97B
$204K ﹤0.01%
+7,072
New +$200K
PHR icon
3593
Phreesia
PHR
$758M
$204K ﹤0.01%
9,612
-2,283
-19% -$49.5K
METC icon
3594
Ramaco Resources Class A
METC
$647M
$203K ﹤0.01%
16,848
-3,617
-18% -$50.3K
BIBL icon
3595
Inspire 100 ETF
BIBL
$497M
$203K ﹤0.01%
+5,333
New +$201K
BGC icon
3596
BGC Group
BGC
$4.8B
$202K ﹤0.01%
24,377
-1,680
-6% -$13.8K
BRCC icon
3597
BRC Inc
BRCC
$212M
$201K ﹤0.01%
32,826
+6,249
+24% +$32.5K
ARQT icon
3598
Arcutis Biotherapeutics
ARQT
$3.3B
$201K ﹤0.01%
21,631
-19,811
-48% -$179K
EWS icon
3599
iShares MSCI Singapore ETF
EWS
$1.17B
$201K ﹤0.01%
+10,475
New +$199K
QDEL icon
3600
QuidelOrtho
QDEL
$959M
$201K ﹤0.01%
6,051
-8,848
-59% -$362K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.